logo
AeroVironment to replace ChampionX in the S&P 400 at open on 7/18

AeroVironment to replace ChampionX in the S&P 400 at open on 7/18

AeroVironment (AVAV) will replace ChampionX Corp. (CHX) in the S&P MidCap 400, effective prior to the opening of trading on Friday, July 18. S&P 500 constituent Schlumberger (SLB) is acquiring ChampionX in a deal expected to be completed July 16, pending final closing conditions.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time
Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time

Yahoo

time2 hours ago

  • Yahoo

Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time

Stock valuations are rising. Rather than the Mag Seven, look at the "Terrific 20." The Terrific 20 stocks includes diverse sectors, indicating a broadening market beyond Big Tech. But some warn of "speculative fervor," given that price multiples, not earnings, are on the rise. Stock valuations are getting frothy again, but this time, it's not all Big Tech's fault. Yes, valuations of the Magnificent Seven stocks — Apple, Amazon, Microsoft, Meta, Alphabet, Nvidia, and Tesla — are back up after since bottoming in April. Yet, the group's 12-month forward price-to-earnings ratio is still down from mid-2024, mid-2023, and 2020 levels. Meanwhile, forward PE ratios on the next 20 stocks in the S&P 500 continue to surge, topping levels seen earlier this year. Their valuations are also higher than at any point over the last decade. Arun Sai, a senior multi-asset strategist at Pictet Asset Management, calls the group the "Terrific 20." Some may see the rising forward expectations for a widening number of stocks as a sign of health, as the rally extends beyond just the most popular stocks. But when stocks rise because of multiple expansion instead of earnings growth, it may be a sign that investor sentiment is becoming overheated. "These companies span a broad set of sectors more closely tied to the real economy, including financials, energy, industrials, consumer, and legacy tech," Sai wrote on Tuesday. "Names like Broadcom, Walmart, JPMorgan, Berkshire Hathaway, Visa, and GE Aerospace now account for ~17% of the MSCI US index, compared to 33% for the Mag 7." "Broader participation is a positive — when it's driven by earnings," he continued. "But when more of the market gets expensive, the narrative that 'US equities aren't overpriced, just a few exceptional companies are' becomes harder to justify." Sai compared the current environment to the so-called "Nifty Fifty" bubble in the 1960s. Richard Bernstein, the founder of Richard Bernstein Advisors and former chief investment strategist at Merrill Lynch, said in June that there are parallels to another famous episode of euphoria—the dot-com bubble of 2000—as the market seems solely focused on an emerging technology. On Wednesday, Bernstein reiterated his skepticism of the rally, noting that the market is still relatively concentrated even if valuations are surging among more than just the top seven stocks. Trading of leveraged ETFs, zero-day options, and low dollar-value stocks is also picking back up, signs of excess optimism, he said. "If you're a trader, I think you should take a deep breath and kind of look at what's going on and realize that everybody's in this huge speculative fervor," Bernstein told Business Insider. "But if you're an investor and you want to be a little patient, I don't think it gets much better than this." "The reckless abandon is going to leave you with so many opportunities," he continued. "It's going to be like post-2000." Most Wall Street strategists don't see a dramatic pullback ahead, and few have made direct comparisons to prior bubble episodes. In recent days, however, some have extended quiet warnings to investors about the market's near-term direction. Ulrike Hoffmann-Burchardi, CIO Americas and global head of equities at UBS Global Wealth Management, said in a note on Tuesday that "investors should be mindful of potential market swings in the coming weeks," and that "capital preservation or phasing-in strategies can be effective in navigating near-term volatility." While valuations are no doubt extended, there's no guarantee a major market top is near, and the AI trade may have room to run as the technology evolves. Meta and Microsoft, for example, reported strong earnings beats this week and gave positive forward guidance, causing shares to soar. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time
Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time

Yahoo

time3 hours ago

  • Yahoo

Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time

Stock valuations are rising. Rather than the Mag Seven, look at the "Terrific 20." The Terrific 20 stocks includes diverse sectors, indicating a broadening market beyond Big Tech. But some warn of "speculative fervor," given that price multiples, not earnings, are on the rise. Stock valuations are getting frothy again, but this time, it's not all Big Tech's fault. Yes, valuations of the Magnificent Seven stocks — Apple, Amazon, Microsoft, Meta, Alphabet, Nvidia, and Tesla — are back up after since bottoming in April. Yet, the group's 12-month forward price-to-earnings ratio is still down from mid-2024, mid-2023, and 2020 levels. Meanwhile, forward PE ratios on the next 20 stocks in the S&P 500 continue to surge, topping levels seen earlier this year. Their valuations are also higher than at any point over the last decade. Arun Sai, a senior multi-asset strategist at Pictet Asset Management, calls the group the "Terrific 20." Some may see the rising forward expectations for a widening number of stocks as a sign of health, as the rally extends beyond just the most popular stocks. But when stocks rise because of multiple expansion instead of earnings growth, it may be a sign that investor sentiment is becoming overheated. "These companies span a broad set of sectors more closely tied to the real economy, including financials, energy, industrials, consumer, and legacy tech," Sai wrote on Tuesday. "Names like Broadcom, Walmart, JPMorgan, Berkshire Hathaway, Visa, and GE Aerospace now account for ~17% of the MSCI US index, compared to 33% for the Mag 7." "Broader participation is a positive — when it's driven by earnings," he continued. "But when more of the market gets expensive, the narrative that 'US equities aren't overpriced, just a few exceptional companies are' becomes harder to justify." Sai compared the current environment to the so-called "Nifty Fifty" bubble in the 1960s. Richard Bernstein, the founder of Richard Bernstein Advisors and former chief investment strategist at Merrill Lynch, said in June that there are parallels to another famous episode of euphoria—the dot-com bubble of 2000—as the market seems solely focused on an emerging technology. On Wednesday, Bernstein reiterated his skepticism of the rally, noting that the market is still relatively concentrated even if valuations are surging among more than just the top seven stocks. Trading of leveraged ETFs, zero-day options, and low dollar-value stocks is also picking back up, signs of excess optimism, he said. "If you're a trader, I think you should take a deep breath and kind of look at what's going on and realize that everybody's in this huge speculative fervor," Bernstein told Business Insider. "But if you're an investor and you want to be a little patient, I don't think it gets much better than this." "The reckless abandon is going to leave you with so many opportunities," he continued. "It's going to be like post-2000." Most Wall Street strategists don't see a dramatic pullback ahead, and few have made direct comparisons to prior bubble episodes. In recent days, however, some have extended quiet warnings to investors about the market's near-term direction. Ulrike Hoffmann-Burchardi, CIO Americas and global head of equities at UBS Global Wealth Management, said in a note on Tuesday that "investors should be mindful of potential market swings in the coming weeks," and that "capital preservation or phasing-in strategies can be effective in navigating near-term volatility." While valuations are no doubt extended, there's no guarantee a major market top is near, and the AI trade may have room to run as the technology evolves. Meta and Microsoft, for example, reported strong earnings beats this week and gave positive forward guidance, causing shares to soar. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know
Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know

Yahoo

time3 hours ago

  • Yahoo

Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know

In the latest trading session, Veeva Systems (VEEV) closed at $281.11, marking a -1.09% move from the previous day. The stock's change was more than the S&P 500's daily loss of 1.6%. On the other hand, the Dow registered a loss of 1.23%, and the technology-centric Nasdaq decreased by 2.24%. The stock of provider of cloud-based software services for the life sciences industry has fallen by 0.03% in the past month, leading the Medical sector's loss of 3.44% and undershooting the S&P 500's gain of 2.25%. The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company's upcoming EPS is projected at $1.9, signifying a 17.28% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $767.61 million, up 13.52% from the year-ago period. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $7.64 per share and revenue of $3.1 billion, indicating changes of +15.76% and +12.78%, respectively, compared to the previous year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Veeva Systems. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Veeva Systems is currently sporting a Zacks Rank of #3 (Hold). With respect to valuation, Veeva Systems is currently being traded at a Forward P/E ratio of 37.18. Its industry sports an average Forward P/E of 26.27, so one might conclude that Veeva Systems is trading at a premium comparatively. Meanwhile, VEEV's PEG ratio is currently 1.6. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 2.78. The Medical Info Systems industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 56, placing it within the top 23% of over 250 industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to follow all of these stock-moving metrics, and many more, on Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Veeva Systems Inc. (VEEV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store